Prices For Specialty Drugs Growing Faster Than Inflation, AARP Says
Executive Summary
Twenty-three of the top 25 specialty drugs used by Medicare Part D beneficiaries had price increases exceeding the general rate of inflation in 2007, according to an "Rx Watchdog Report" published by the AARP Public Policy Institute